Russian, U.S. Firms To Invest In Biotech | Chemical & Engineering News
Volume 90 Issue 11 | p. 28 | Concentrates
Issue Date: March 12, 2012

Russian, U.S. Firms To Invest In Biotech

Department: Business
Keywords: venture capital, Russia, biotechnology, pharmaceuticals

Rusnano, a Russian government-owned investment firm, has joined with the U.S. venture capital firm Domain Associates to create a life sciences investment fund. The partners expect to invest about $760 million in up to 20 U.S.-based start-up companies and in a pharmaceutical plant in Russia. Inventions from the portfolio companies are to be made and sold in Russia and other C.I.S. countries. The technology transfer is intended to help modernize Russian health care through new pharmaceuticals, medical devices, and diagnostics. The partnership also plans to manage late-stage clinical trials in Russia to support regulatory approval in Russia, the U.S., and other markets.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment